乙胺碘呋酮联合卡托普利、氯沙坦片治疗阵发性房颤的疗效观察
参考文献2
-
1王宏宇,胡大一.血管紧张素转换酶抑制剂与心血管危险控制——临床试验[J].中国医刊,2005,40(5):61-62. 被引量：1
-
2殷跃辉,刘增长,杨小渝,董军,高大中,佘强,熊杰熙,黄祖荣.小剂量胺碘酮与培哚普利联合治疗阵发性心房颤动的临床疗效[J].中国循环杂志,2004,19(1):19-21. 被引量：45
二级参考文献12
-
1[1]Roy D,Talajic M,Dorian P, et al. Amiodarnoe to prevent recurrence of atrial fibrillation. Canadian Trial of atrial fibrillation Investigators. N Engl J Med, 2000,342: 913-920.
-
2[2]Kochiadakis GE, Igoumenidis NE, Marketou ME, et al. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol, 1998,81:995-998.
-
3[3]Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation, 1995,92:1954-1968.
-
4[4]Goette A, Honeycutt C,Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation, 1996, 94: 2968-2974.
-
5[5]Tieleman RG, Langen CDJD, Gelder ICV, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation, 1997,95:1945-1953.
-
6[6]Wijffels MCEF, Kirchhol CJHJ, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats:role of neurohumoral changes,ischemia,atrial stretch,and high rate of electrical activation. Circulation, 1997,96: 3710-3720.
-
7[7]Tieleman RG, Gelder ICV, Crijns HJGM, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-reduced electrical remodeling of atria? J Am Coll Cardil, 1998,31:167-173.
-
8[8]Van Den Berg MP, Crijns HJGM, Van Veldhuisen DJ, et al. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail, 1995,1: 355-364.
-
9[9]Hideko N, Koickiro K, Hidenori U, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation. Circulation, 2000, 101:2612-2617.
-
10[10]Goette A, Amdt M, Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in human. Circulation, 2000,101:2678-2681.
共引文献44
-
1孙会,王君库,王晓培.小剂量胺碘酮治疗心房颤动78例疗效观察[J].中国煤炭工业医学杂志,2005,8(6):615-615.
-
2贾新未,邸丕凡,曹艳霞,宋书江,潘焕军,陈艳霞.血浆肾素-血管紧张素-醛固酮水平对胺碘酮转复房颤患者窦性心律效果的影响[J].河北医药,2006,28(3):174-175. 被引量：3
-
3贾新未,邸丕凡,高友军,刘良义,尹博英,潘焕军,陈艳霞.血管紧张素转换酶抑制剂协助胺碘酮转复持续性心房颤动患者窦性心律的临床研究[J].河北医药,2006,28(4):254-255.
-
4殷跃辉,刘增长,吴近近,代引,苏立,兰先彬,凌智瑜,杨小渝,罗开良.胺碘酮与氯沙坦、培哚普利联合治疗阵发性心房颤动的前瞻、随机开放研究[J].中华心血管病杂志,2006,34(4):299-302. 被引量：72
-
5贾新未,王晓娜,邸丕凡,李京波,魏盟.血管紧张素转化酶抑制药协助心房颤动复律的维持[J].岭南心血管病杂志,2006,12(4):289-291.
-
6胡永寸.贝那普利联合地尔硫治疗伴左房扩大的阵发性心房颤动[J].临床荟萃,2006,21(19):1417-1418. 被引量：1
-
7贾新未,邸丕凡,曹艳霞.血浆肾素-血管紧张素-醛固酮水平在心房颤动转律中的作用[J].中国煤炭工业医学杂志,2006,9(12):1250-1251. 被引量：1
-
8杨勇.雅施达协助心房颤动复律的临床观察[J].内科,2007,2(1):17-19.
-
9李华,梁军.西拉普利治疗老年人心房颤动的临床观察[J].中国医药导报,2007,4(03Z):51-52. 被引量：1
-
10李小芳,白敏聪,张润华.胺碘酮与缬沙坦治疗阵发性房颤67例[J].中西医结合心脑血管病杂志,2007,5(2):171-171. 被引量：6
-
1裘宇芳.胺碘酮对心房颤动复律及转复后维持窦律的疗效分析[J].浙江实用医学,1998,3(4):24-25.
-
2张景富,尹春元.静脉应用胺碘酮治疗心房颤动复律的疗效观察[J].中国药房,2011,22(24):2288-2290. 被引量：4
-
3许志强,王秋英,金梅.胺碘酮治疗近期心房颤动112例疗效及安全性观察[J].中国基层医药,2008,15(5):854-854. 被引量：4
-
4万梦鹏.葛根素联合胺腆酮治疗心房颤动(附87例观察)[J].航空航天医药,2009,20(12):17-18.
-
5樊红兵,谈佳.84例老年人心房颤动复律疗效观察[J].中国实用乡村医生杂志,2013(19):37-38.
-
6李颖,温春琪,朱静,胡军.静脉与口服联合应用胺碘酮行房颤复律46例分析[J].中国误诊学杂志,2010,10(13):3206-3207.
-
7汪世军,祝玉娟,唐关敏.缬沙坦联合胺碘酮对持续性心房颤动复律及复律后窦性心律维持率的影响[J].心电与循环,2014,33(1):44-46. 被引量：2
-
8丁原森,陈吉香,韩安芹.胺碘酮对心房颤动复律3例疗效观察[J].中国医药导报,2007,4(07S):93-93.
-
9饶志荣,邱汉婴,杨友祥,王宁生,王霞,方快发.培哚普利对心房颤动复律并维持窦性心律的临床疗效[J].医学理论与实践,2007,20(2):132-134.
-
10胡胜连.胺碘酮在心房颤动复律后维持窦性心律的疗效观察[J].临床合理用药杂志,2010,3(11):43-43. 被引量：3
